Michael L. Fantozzi
Mergers & Acquisitions
- Hyperfine, Inc.'s (Nasdaq: HYPR) business combination, valued at $580 million, with Liminal Sciences and the SPAC, HealthCor Catalio Acquisition Corp.
- The Metals Company’s (Nasdaq: TMC) (formerly DeepGreen Metals) business combination, valued at $2.9 billion, with the SPAC, Sustainable Opportunities Acquisition Corporation
- Azenta Life Sciences' (Nasdaq: AZTA) (formerly Brooks Automation, Inc.) $3 billion sale of its Semiconductor Solutions business to private equity firm Thomas H. Lee Partners, L.P.
- Optum’s acquisition of Atrius Health
- Quantum-SI’s (Nasdaq: QSI) $1.46 billion business combination with the SPAC, HighCape Capital Acquisition Corp.
- Butterfly Network’s (NYSE: BFLY) $1.5 billion business combination with the SPAC, Longview Acquisition Corp.
- QIAGEN in its proposed $12.5 billion sale to Thermo Fisher Scientific
- Brooks Automation’s approximately $450 million purchase of genomics service provider Genewiz Group
- Brooks Automation’s $675 million sale of its semiconductor cryogenics business to Edwards Vacuum LLC (a member of the Atlas Copco Group)
- John Hancock Financial Network’s sale of Signator Investors to Advisor Group
- Connance’s sale to Waystar Health
- Optum’s purchase of Reliant Medical Group
- Fidelity’s purchase of a software solutions company
- C&S Wholesale Grocers’ purchase of the assets of Davidson Co., Inc.
- Brooks Automation’s $127 million purchase of BioStorage Technologies
- John Hancock Financial Network’s purchase of the assets of Transamerica Financial Advisors
- Naurex’s sale to Allergan
- Leerink Swann’s sale of the assets of Leerink Swann Consulting to NCI Healthcare
- John Hancock Financial Network’s purchase of Symetra Investment Services
- C&S Wholesale Grocers’ purchase of the assets of Associated Wholesalers
- Humedica’s sale to UnitedHealth Group
- Piramal Healthcare Limited’s $635 million purchase of Decision Resources Group
- iMDsoft’s $60 million sale to TPG
- Ion Torrent Systems’ $725 million sale to Life Technologies
- Amicas’ $267 million sale to Merge Healthcare
- Vertex Pharmaceuticals’ $400 million purchase of ViroChem Pharma
- iBasis’ $100 million sale to Royal KPN
- Qiagen’s $1.6 billion purchase of Digene Corporation
Public Offerings
- Vertex Pharmaceuticals in over $2.5 billion in equity and debt offerings
Michael also serves as counsel to Brooks Automation and John Hancock Life Insurance Company. Private company clients include C&S Wholesale Grocers, LAM Therapeutics and W.E. Aubuchon Co.
Case Study
The proposed sale to private equity firm Thomas H. Lee Partners, L.P., will allow Brooks to accelerate the growth of its other global business, Life Sciences, which will operate as a standalone publicly traded company under a new name yet to be announced.
Case Study
Mintz is advising DeepGreen Metals Inc., a company developing a new source of electric vehicle battery metals from polymetallic nodules found on the seafloor, in its proposed merger with Sustainable Opportunities Acquisition Corporation, a special purpose acquisition company (SPAC) focused on ESG.
Case Study
Mintz analyzed PitchBook data to produce an in-depth report on the record rise in special purpose acquisition company (SPAC) fundraising in the US since 2020 and the recent increase in SPAC merger activity. We also explore how SPACs could evolve and litigation challenges to SPAC IPOs and transactions.
Case Study
Mintz is acting as legal advisor to Quantum-SI Incorporated, developer of a pioneering semiconductor chip to sequence proteins, in its proposed business combination with HighCape Capital Acquisition Corp., a special purpose acquisition company (SPAC) sponsored by growth equity investment firm HighCape Capital LP.
Case Study
Mintz served as legal advisor to Butterfly Network Inc., an innovative digital health company, in its merger with Longview Acquisition Corp., a special purpose acquisition company (SPAC) sponsored by Glenview Capital Management, LLC.
Case Study
Mintz represented clinical-stage biopharmaceutical company Naurex Inc., which develops therapies for central nervous system disorders, in its acquisition by global pharmaceutical company Allergan PLC for $560 million plus potential milestone payments. Naurex’s platform was spun out into a new company.
Case Study
Mintz represented John Hancock Financial Network in its acquisition of certain assets of Transamerica Financial Advisors Inc. The deal grew assets under John Hancock’s broker-dealer to nearly $50 billion.
Case Study
Mintz achieved a legal victory for longtime client Shari Redstone in a contentious legal battle concerning media company Viacom, Inc.’s board and corporate governance. The global settlement dismissed all suits against Ms. Redstone and her father Sumner and altered the Viacom board.